| Code | 6400C | ||||||||||
| MA number | 12/0390/17-S | ||||||||||
| Product Form: | tbl mnd 100x100 mg (blis.Al/Al) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A., Greece | ||||||||||
| Therapeutic Class: | 12 - ANTIANAEMICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Container: | blister Al/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10a well-established use application |
| MA issued: | 19.12.2017 |
| Validity: | 05.07.2027 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| PIL: |
PIL_Hemafer 100 mg_tbl mnd_12/2017_REG.docx
|
| SPC: |
SPC_Hemafer 100 mg_tbl mnd_12/2017_REG.doc
|
| Safety feature | Yes |
| Data update: | 27.04.2022 |
